AI-CARE Study

Cross-source consensus on AI-CARE Study from 1 sources and 5 claims.

1 sources · 5 claims

Other

AI-CARE is a double-blind, crossover, non-inferiority randomised controlled trial comparing AI-generated and human-generated digital health messages. — A double-blind, crossover, non-inferiority randomised controlled trial where primary care providers and patients compare human-generated and AI-generated digital health messages: the AI-CARE study protocol
Data collection began on 30 May 2025 and is expected to finish at the end of May 2026. — A double-blind, crossover, non-inferiority randomised controlled trial where primary care providers and patients compare human-generated and AI-generated digital health messages: the AI-CARE study protocol
The study is registered on ClinicalTrials.gov as NCT06997107. — A double-blind, crossover, non-inferiority randomised controlled trial where primary care providers and patients compare human-generated and AI-generated digital health messages: the AI-CARE study protocol
The study evaluates 192 messages across 48 topics over 12 months. — A double-blind, crossover, non-inferiority randomised controlled trial where primary care providers and patients compare human-generated and AI-generated digital health messages: the AI-CARE study protocol
The trial is conducted in English and French in Canada. — A double-blind, crossover, non-inferiority randomised controlled trial where primary care providers and patients compare human-generated and AI-generated digital health messages: the AI-CARE study protocol